Cited 0 times in 
Cited 0 times in 
Brigatinib (BRG) vs crizotinib (CRZ) in anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor-naive ALK+ non-small cell lung cancer (NSCLC): ALTA-1L final results
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2023-06-02T00:43:44Z | - |
| dc.date.available | 2023-06-02T00:43:44Z | - |
| dc.date.issued | 2022-04 | - |
| dc.identifier.issn | 0923-7534 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194377 | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Oxford University Press | - |
| dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Brigatinib (BRG) vs crizotinib (CRZ) in anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor-naive ALK+ non-small cell lung cancer (NSCLC): ALTA-1L final results | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | M. Tiseo | - |
| dc.contributor.googleauthor | S. Popat | - |
| dc.contributor.googleauthor | H.R. Kim | - |
| dc.contributor.googleauthor | M-J. Ahn | - |
| dc.contributor.googleauthor | J.C. Yang | - |
| dc.contributor.googleauthor | J-Y. Han | - |
| dc.contributor.googleauthor | M.J. Hochmair | - |
| dc.contributor.googleauthor | K.H. Lee | - |
| dc.contributor.googleauthor | A. Delmonte | - |
| dc.contributor.googleauthor | M.R. Garcia Campelo | - |
| dc.contributor.googleauthor | D-W. Kim | - |
| dc.contributor.googleauthor | F. Griesinger | - |
| dc.contributor.googleauthor | E. Felip | - |
| dc.contributor.googleauthor | R. Califano | - |
| dc.contributor.googleauthor | A.I. Spira | - |
| dc.contributor.googleauthor | S.N. Gettinger | - |
| dc.contributor.googleauthor | H.M. Lin | - |
| dc.contributor.googleauthor | Y. Liu | - |
| dc.contributor.googleauthor | F. Vranceanu | - |
| dc.contributor.googleauthor | D.R. Camidge | - |
| dc.identifier.doi | 10.1016/j.annonc.2022.02.038 | - |
| dc.relation.journalcode | J00171 | - |
| dc.identifier.eissn | 1569-8041 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422001545 | - |
| dc.citation.volume | 33 | - |
| dc.citation.number | Suppl 2 | - |
| dc.citation.startPage | S44 | - |
| dc.citation.endPage | S45 | - |
| dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 2) : S44-S45, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.